Squarepoint’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.5K | Buy |
+35,826
| New | +$88.5K | ﹤0.01% | 2521 |
|
|
2024
Q4 | – | Sell |
-124,369
| Closed | -$481K | – | 3125 |
|
|
2024
Q3 | $481K | Buy |
124,369
+60,908
| +96% | +$236K | ﹤0.01% | 1775 |
|
|
2024
Q2 | $326K | Buy |
63,461
+3,895
| +7% | +$20K | ﹤0.01% | 1926 |
|
|
2024
Q1 | $417K | Sell |
59,566
-11,957
| -17% | -$83.7K | ﹤0.01% | 1772 |
|
|
2023
Q4 | $634K | Buy |
71,523
+56,033
| +362% | +$496K | ﹤0.01% | 1567 |
|
|
2023
Q3 | $148K | Buy |
+15,490
| New | +$148K | ﹤0.01% | 2190 |
|